Microemulsions for oral administration and their therapeutic applications

Bibliography

• Hoar TP, Schulman JH. Transparent water-in-oil dispersions: the oleopathic hydro-micelle. Nature 1943;152:102-3
   Google Scholar
• Schulman J, Stoeckenius W. Mechanism of formation and structure of micro emulsions by electron microscopy. J Phys Chem 1959;63:1677-80
   Web of Science ®Google Scholar
• Danielsson I, Lindman B. The definition of microemulsion. Colloids Surf 1981;3:391-2
   Web of Science ®Google Scholar
• Spernath A, Aserin A. Microemulsions as carriers for drugs and nutraceuticals. Adv Colloid Interface Sci 2006;128-130:47-64
   PubMed Web of Science ®Google Scholar
• Shafiq S, Shakeel F, Talegaonkar S, Design and development of oral oil in water ramipril nanoemulsion formulation: in vitro and in vivo assessment. J Biomed Nanotechnol 2007;3:28-44
   Web of Science ®Google Scholar
• Muellertz A, Ogbonna A, Ren S, New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. J Pharm Pharmacol 2010;62:1622-36
   PubMed Web of Science ®Google Scholar
• Noh GJ, Lee E-H, Lee SH, Physicochemical properties, pharmacokinetics, and pharmacodynamics of a reformulated microemulsion propofol in rats. Anesthesiology 2008;109:436-47
   PubMed Web of Science ®Google Scholar
• Paolino D, Ventura C, Nistico S, Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int J Pharm 2002;244:21-31
   PubMed Web of Science ®Google Scholar
• Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm 2007;329:166-72
   PubMed Web of Science ®Google Scholar
• Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 2006;29:278-87
   PubMed Web of Science ®Google Scholar
• Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur J Pharm Sci 2000;11(Suppl 2):S93-8
   PubMed Web of Science ®Google Scholar
• Gelderblom H, Verweij J, Nooter K, Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 2001;37:1590-8
   PubMed Web of Science ®Google Scholar
• Riehm H, Biedler JL. Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin. Cancer Res 1972;32:1195-200
   PubMed Web of Science ®Google Scholar
• Coon JS, Knudson W, Clodfelter K, Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance. Cancer Res 1991;51:897-902
   PubMed Web of Science ®Google Scholar
• Zordan-Nudo T, Ling V, Liu Z, Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance. Cancer Res 1993;53:5994-6000
   PubMed Web of Science ®Google Scholar
• Charman SA, Charman WN, Rogge MC, Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res 1992;9:87-93
   PubMed Web of Science ®Google Scholar
• Shah N, Carvajal M, Patel C, Self-emulsifying drug-delivery systems (SEDDS) with polyglycolyzed glycerides for improving in-vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 1994;106:15-23
   Web of Science ®Google Scholar
• Porter CJH, Charman WN. Uptake of drugs into the intestinal lymphatics after oral administration. Adv Drug Deliv Rev 1997;25:71-89
   Web of Science ®Google Scholar
• Grove M, Mullertz A, Nielsen J, Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides. Eur J Pharm Sci 2006;28:233-42
   PubMed Web of Science ®Google Scholar
• Schulman JH, Montagne JB. Formation of microemulsions by aminoalkyl alcohols. Ann N Y Acad Sci 1961;92:366-71
   PubMed Web of Science ®Google Scholar
• Aboofazeli R, Patel N, Thomas M, Investigations into the formation and characterization of phospholipid microemulsions. IV. Pseudo-ternary phase-diagrams of systems containing water-lecithin-alcohol and oil – the influence of oil. Int J Pharm 1995;125:107-16
   Web of Science ®Google Scholar
• Attivi D, Ajana I, Astier A, Development of microemulsion of mitotane for improvement of oral bioavailability. Drug Dev Ind Pharm 2010;36:421-7
   PubMed Web of Science ®Google Scholar
• Shafiq S, Shakeel F, Talegaonkar S, Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 2007;66:227-43
   PubMed Web of Science ®Google Scholar
• Kang B, Lee J, Chon S, Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 2004;274:65-73
   PubMed Web of Science ®Google Scholar
• Lu J-L, Wang J-C, Zhao S-X, Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice. Eur J Pharm Biopharm 2008;69:899-907
   PubMed Web of Science ®Google Scholar
• Osipow LI. Transparent emulsions. J Soc Cosmet Chem 1963;14:277-85
   Web of Science ®Google Scholar
• He L, Wang G-L, Zhang Q. An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile. Int J Pharm 2003;250:45-50
   PubMed Web of Science ®Google Scholar
• Patil P, Patil V, Paradkar A. Formulation of a self-emulsifying system for oral delivery of simvastatin: in vitro and in vivo evaluation. Acta Pharm 2007;57:111-22
   PubMedGoogle Scholar
• Prince LM. A theory of aqueous emulsions. I. Negative interfacial tension at the oil/water interface. J Colloid Interface Sci 1967;23:165-73
   Web of Science ®Google Scholar
• Weiss J. Static and dynamic interfacial tension analysis. In: Wrolstad RE, Decker EA, Schwartz SJ, editors. Handbook of food analytical chemistry, water, proteins, enzymes, lipids, and carbohydrates. Wiley-Interscience; Hoboken, New Jersey: 2005. p. 631-46
   Google Scholar
• Lim H, Lee S, Mo D, Effect of cosurfactant on microemulsion phase behavior in NP7 surfactant system. J Korean Ind Eng Chem 2011;22:416-22
   Google Scholar
• Bellocq AM, Bourbon D, Lemanceau B, Thermodynamic, interfacial, and structural properties of polyphasic microemulsion systems. J Colloid Interface Sci 1982;89:427-40
   Web of Science ®Google Scholar
• Chen LH, Zhao XT, Wu DZ, Screening the prescription microemulsion by conductivity and the phase behavior. Chin Pharm J 2011;46:40-3
   Google Scholar
• Brime B, Frutos P, Bringas P, Comparative pharmacokinetics and safety of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and amphotericin B deoxycholate in animal models. J Antimicrob Chemother 2003;52:103-9
   PubMed Web of Science ®Google Scholar
• Gershanik T, Benzeno S, Benita S. Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge. Pharm Res 1998;15:863-9
   PubMed Web of Science ®Google Scholar
• Yang S, Gursoy R, Lambert G, Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors. Pharm Res 2004;21:261-70
   PubMed Web of Science ®Google Scholar
• Mandal S. Microemulsion drug delivery system: design and development for oral bioavailability enhancement of lovastatin. S Afr Pharm J 2011;78:44-50
   Google Scholar
• Patel V, Kukadiya H, Mashru R, Development of microemulsion for solubility enhancement of clopidogrel. Iran J Pharm Res 2010;9:327-34
   PubMed Web of Science ®Google Scholar
• Pal R. Techniques for measuring the composition (Oil and Water-Content) of emulsions - a State-of-the-art review. Colloid Surf A 1994;84:141-93
   Web of Science ®Google Scholar
• Araya H, Tomita M, Hayashi M. The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion III: the permeation mechanism of a poorly water soluble drug entrapped O/W microemulsion in rat isolated intestinal membrane by the Ussing chamber method. Drug Metab Pharmacokinet 2006;21:45-53
   PubMed Web of Science ®Google Scholar
• Malenkov AG, Bogatyreva SA, Bozhkova VP, Reversible alterations of the surface of ascites tumour cells induced by a surface-active substance, Tween 60. Exp Cell Res 1967;48:307-18
   PubMedGoogle Scholar
• Yin Y-M, Cui F-D, Mu C-F, Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Control Release 2009;140:86-94
   PubMed Web of Science ®Google Scholar
• Brossard D, Crauste-Manciet S, Saleh M, Methods for making a formulation and use thereof for administering polar drugs. WO2010067035A1; 2010
   Google Scholar
• Han D-H, Jin Z-H, Jin Y-Z, Thermal reversible microemulsion system for poorly water-soluble YH439 for oral delivery. Chem Pharm Bull 2010;58:11-15
   PubMed Web of Science ®Google Scholar
• Karasulu H. Microemulsions as novel drug carriers: the formation, stability, applications and toxicity. Exp Opin Drug Deliv 2008;5:119-35
   PubMed Web of Science ®Google Scholar
• Sha X, Yan G, Wu Y, Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells. Eur J Pharm Sci 2005;24:477-86
   PubMed Web of Science ®Google Scholar
• Masungi C, Mensch J, Van Dijck A, Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates. Pharmazie 2008;63:194-9
   PubMed Web of Science ®Google Scholar
• Kansy M, Senner F, Gubernator K. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem 1998;41:1007-10
   PubMed Web of Science ®Google Scholar
• Chen X, Murawski A, Patel K, A novel design of artificial membrane for improving the PAMPA model. Pharm Res 2008;25:1511-20
   PubMed Web of Science ®Google Scholar
• Kahan BD. Cyclosporine. N Engl J Med 1989;321:1725-38
   PubMed Web of Science ®Google Scholar
• Beveridge T, Gratwohl A, Michot F, Cyclosporin A: pharmacokinetics after a single dose in man and serum levels after multiple dosing in recipients of allogeneic bone-marrow grafts. Curr Ther Res 1981;30:5-18
   Web of Science ®Google Scholar
• Frey FJ, Horber FF, Frey BM. Trough levels and concentration time curves of cyclosporine in patients undergoing renal transplantation. Clin Pharmacol Ther 1988;43:55-62
   PubMed Web of Science ®Google Scholar
• Ptachcinski RJ, Venkataramanan R, Burckart GJ. Clinical pharmacokinetics of cyclosporin. Clin Pharmacokinet 1986;11:107
   PubMed Web of Science ®Google Scholar
• Mehta MU, Venkataramanan R, Burckart GJ, Effect of bile on cyclosporin absorption in liver transplant patients. Br J Clin Pharmacol 1988;25:579-84
   PubMed Web of Science ®Google Scholar
• Venkataramanan R, Burckhart GJ, Ptachcinski RJ. Pharmacokinetics and monitoring of cyclosporine following orthotopic liver transplantation. Semin Liver Dis 1985;5:357-68
   PubMed Web of Science ®Google Scholar
• Trull AK, Tan KKC, Tan L, Absorption of cyclosporin from conventional and new microemulsion oral formulations in liver transplant recipients with external biliary diversion. Br J Clin Pharmacol 1995;39:627-31
   PubMed Web of Science ®Google Scholar
• Kovarik JM, Mueller EA, Van Bree JB, Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. J Pharm Sci 1994;83:444-6
   PubMed Web of Science ®Google Scholar
• Trull AK, Tan KK, Uttridge J, Cyclosporin absorption from microemulsion formulation in liver transplant recipient. Lancet 1993;341:433
   PubMed Web of Science ®Google Scholar
• Grevel J, Nesch E, Abisch E, Pharmacokinetics of oral cyclosporin a (Sandimmun) in healthy subjects. Eur J Clin Pharmacol 1986;31:211-16
   PubMed Web of Science ®Google Scholar
• Drewe J, Meier R, Vonderscher J, Enhancement of the oral absorption of cyclosporin in man. Br J Clin Pharmacol 1992;34:60-4
   PubMed Web of Science ®Google Scholar
• Kovarik JM, Mueller EA, Van Bree JB, Within-day consistency in cyclosporine pharmacokinetics from a microemulsion formulation in renal transplant patients. Ther Drug Monit 1994;16:232-7
   PubMed Web of Science ®Google Scholar
• Mueller EA, Kovarik JM, Van Bree JB, Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation. Pharm Res 1994;11:301-4
   PubMed Web of Science ®Google Scholar
• Griffin BT, O'Driscoll CM. A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model. J Pharm Pharmacol 2006;58:917-25
   PubMed Web of Science ®Google Scholar
• Allard JP, Aghdassi E, Chau J, Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects. Aids 1998;12:1653
   PubMed Web of Science ®Google Scholar
• Surjyanarayan M, Snigdha S M, Naazneen S, Design and development of Saquinavir microemulsion for the oral bioavailability enhancement. Int J Pharm Tech Res 2009;1:1442-8
   Google Scholar
• Hugen PWH, Burger DM, Koopmans PP, Saquinavir soft-gel capsules (Fortovase) give lower exposure than expected, even after a high-fat breakfast. Pharm World Sci 2002;24:83-6
   PubMed Web of Science ®Google Scholar
• Fatouros DG, Karpf DM, Nielsen FS, Clinical studies with oral lipid based formulations of poorly soluble compounds. Ther Clin Risk Manage 2007;3:591-604
   PubMedGoogle Scholar
• Goddeeris C, Coacci J, Van den Mooter G. Correlation between digestion of the lipid phase of SMEDDS and release of the anti-HIV drug UC 781 and the anti-mycotic drug enilconazole from SMEDDS. Eur J Pharm Biopharm 2007;66:173-81
   PubMed Web of Science ®Google Scholar
• Ghosh PK, Majithiya RJ, Umrethia ML, Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability. AAPS PharmSciTech 2006;7:E1-6
   PubMedGoogle Scholar
• Chouksey R, Pandey H, Jain AK, Preparation and evaluation of the self emulsifying drug delivery system containing atorvastatin HMG-CoA inhibiter. Int J Pharm Pharm Sci 2011;3:147-52
   Google Scholar
• Agueros M, Ruiz-Gaton L, Vauthier C, Combined hydroxypropyl-beta-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel. Eur J Pharm Sci 2009;38:405-13
   PubMed Web of Science ®Google Scholar
• Sharma U, Balasubramanian S, Straubinger R. Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins. J Pharm Sci 1995;84:1223-30
   PubMed Web of Science ®Google Scholar
• Perez EA. Novel enhanced delivery taxanes: an update. Semin Oncol 2007;34:S1-5
   PubMedGoogle Scholar
• King KM, Lupichuk S, Baig L, Optimal use of taxanes in metastatic breast cancer. Journal 2009;16:8-20
   Google Scholar
• Michaud LB, Valero V, Hortobagyi G. Risks and benefits of taxanes in breast and ovarian cancer. Drug Saf 2000;23:401
   PubMed Web of Science ®Google Scholar
• Fanucchi M, Khuri FR. Taxanes in the treatment of non-small cell lung cancer. Treat Res Med 2006;5:181-91
   PubMedGoogle Scholar
• Schrijvers D, Vermorken JB. Taxanes in head and neck cancer. Future Oncol 2005;1:829-39
   PubMedGoogle Scholar
• Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 2008;132:171-83
   PubMed Web of Science ®Google Scholar
• Khandavilli S, Panchagnula R. Nanoemulsions as versatile formulations for paclitaxel delivery: peroral and dermal delivery studies in rats. J Investig Dermatol 2007;127:154-62
   PubMed Web of Science ®Google Scholar
• Nichols J, Richardson A. Effects of DDD on steroid response and blood flow through the adrenal after ACTH. Proc Soc Exp Biol Med 1960;104:539-42
   PubMed Web of Science ®Google Scholar
• Wallace E, Silverstein J, Villadolid L, Cushing's syndrome due to adrenocortical hyperplasia. Treatment with an inhibitor of adrenocortical secretions. N Engl J Med 1961;265:1088-93
   PubMed Web of Science ®Google Scholar
• Attivi D, Gibaud S. Place du mitotane dans la prise en charge du carcinome corticosurrenalien. Act Pharm Hosp 2011;7:39-41
   Google Scholar
• Batung F, Chajmowics M. Self-microemulsifying mitotane composition. WO20101136952; 2010
   Google Scholar
• Santos-Magalhaes NS, Pontes A, Pereira VM, Colloidal carriers for benzathine penicillin G: nanoemulsions and nanocapsules. Int J Pharm 2000;208:71-80
   PubMed Web of Science ®Google Scholar
• Heo M, Piao Z, Kim T, Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole. Arch Pharm Res 2005;28:604-11
   PubMed Web of Science ®Google Scholar
• Gui S-Y, Wu L, Peng DY, Preparation and evaluation of a microemulsion for oral delivery of berberine. Pharmazie 2008;63:516-19
   PubMed Web of Science ®Google Scholar
• Chen B, Chow M. Focus on carvedilol: a novel beta-adrenergic blocking agent for the treatment of congestive heart failure. Formulary 1997;32:795-805
   Web of Science ®Google Scholar
• Morgan T. Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin Pharmacokinet 1994;26:335-46
   PubMed Web of Science ®Google Scholar
• Neugebauer G, Akpan W, von Mollendorff E, Pharmacokinetics and disposition of carvedilol in humans. J Cardiovasc Pharmacol 1987;10(Suppl 11):S85-8
   PubMedGoogle Scholar
• Wei L, Sun P, Nie S, Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev Ind Pharm 2005;31:785-94
   PubMed Web of Science ®Google Scholar
• Chinsangaram J, Honeychurch KM, Tyavanagimatt SR, Pharmacokinetic comparison of a single oral dose of polymorph form I versus form V capsules of the anti-orthopoxvirus compound ST-246(R) in human volunteers. Antimicrob Agents Chemother 2012. [Epub ahead of print]
   Web of Science ®Google Scholar
• Yong CS, Lee M-K, Park Y-J, Enhanced oral bioavailability of ibuprofen in rats by poloxamer gel using poloxamer 188 and menthol. Drug Dev Ind Pharm 2005;31:615-22
   PubMed Web of Science ®Google Scholar
• Saffoon N, Uddin R, Huda NH, Enhancement of oral bioavailability and solid dispersion: a review. J Appl Pharm Sci 2011;1:13-20
   Google Scholar
• Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47-60
   PubMed Web of Science ®Google Scholar
• Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev 2012;64:557-70
   PubMed Web of Science ®Google Scholar
• Florence AT. Issues in oral nanoparticle drug carrier uptake and targeting. J Drug Target 2004;12:65-70
   PubMed Web of Science ®Google Scholar
• Wong S, Kellaway I, Murdan S. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. Int J Pharm 2006;317:61-8
   PubMed Web of Science ®Google Scholar
• Muller R, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv Drug Deliv Rev 2001;47:3-19
   PubMed Web of Science ®Google Scholar
• Kanwar JR, Long BM, Kanwar RK. The use of cyclodextrins nanoparticles for oral delivery. Curr Med Chem 2011;18:2079-85
   PubMed Web of Science ®Google Scholar
• Ning X, Sun J, Han X, Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques. Drug Dev Ind Pharm 2011;37:727-36
   PubMed Web of Science ®Google Scholar
• Dai J, Nagai T, Wang X, pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A. Int J Pharm 2004;280:229-40
   PubMed Web of Science ®Google Scholar
• Wang X, Dai J, Chen Z, Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration. J Control Release 2004;97:421-9
   PubMed Web of Science ®Google Scholar
• Italia J, Bhatt D, Bhardwaj V, PLGA nanoparticles for oral delivery of cyclosporine: Nephrotoxicity and pharmacokinetic studies in comparison to Sandimmun Neoral®.. J Control Release 2007;119:197-206
   PubMed Web of Science ®Google Scholar
• El-Shabouri M. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int J Pharm 2002;249:101-8
   PubMed Web of Science ®Google Scholar
• Muller RH, Runge S, Ravelli V, Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN®) versus drug nanocrystals. Int J Pharm 2006;317:82-9
   PubMed Web of Science ®Google Scholar
• Lai J, Lu Y, Yin Z, Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles. Int J Nanomed 2010;5:13-23
   PubMed Web of Science ®Google Scholar
• Ankola DD, Battisti A, Solaro R, Nanoparticles made of multi-block copolymer of lactic acid and ethylene glycol containing periodic side-chain carboxyl groups for oral delivery of cyclosporine A. J R Soc Interface 2010;7(Suppl 4):S475-81
   PubMedGoogle Scholar
• Aliabadi HM, Brocks DR, Lavasanifar A. Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution. Biomaterials 2005;26:7251-9
   PubMed Web of Science ®Google Scholar
• Guo J, Wu T, Ping Q, Solubilization and pharmacokinetic behaviors of sodium cholate/lecithin-mixed micelles containing cyclosporine A. Drug Deliv 2005;12:35-9
   PubMed Web of Science ®Google Scholar
• Lee E, Lee S, Choi H, Bioavailability of cyclosporin A dispersed in sodium lauryl sulfate-dextrin based solid microspheres. Int J Pharm 2001;218:125-31
   PubMed Web of Science ®Google Scholar
• Guo J, Ping Q, Chen Y. Pharmacokinetic behavior of cyclosporin A in rabbits by oral administration of lecithin vesicle and Sandimmun Neoral. Int J Pharm 2001;216:17-21
   PubMed Web of Science ®Google Scholar
• Shah NM, Parikh J, Namdeo A, Preparation, characterization and in vivo studies of proliposomes containing Cyclosporine A. J Nanosci Nanotechnol 2006;6:2967-73
   PubMed Web of Science ®Google Scholar
• Liu C, Wu J, Shi B, Enhancing the bioavailability of cyclosporine a using solid dispersion containing polyoxyethylene (40) stearate. Drug Dev Ind Pharm 2006;32:115-23
   PubMed Web of Science ®Google Scholar
• Chen M, Wang J, Tzen J. Elevating Bioavailability of cyclosporine A via encapsulation in artificial oil bodies stabilized by caleosin. Biotech Prog 2005;21:1297-301
   PubMed Web of Science ®Google Scholar
• Hu L, Yang J, Liu W, Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability. Drug Deliv 2011;18:90-5
   PubMed Web of Science ®Google Scholar
• Nazar MF, Khan AM, Shah SS. Microemulsion system with improved loading of piroxicam: a study of microstructure. AAPS PharmSciTech 2009;10:1286-94
   PubMed Web of Science ®Google Scholar
• Zheng JY, Fulu M-Y. Decrease of genital organ weights and plasma testosterone levels in rats following oral administration of leuprolide microemulsion. Int J Pharm 2006;307:209-15
   PubMed Web of Science ®Google Scholar
• Gupta A. Design and development of microemulsion drug delivery system of nifedipine for improvement of oral bioavailability. Res J Pharm Sci Biotech 2011;1:51-6
   Google Scholar
• O'Driscoll CM. Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 2002;15:405-15
   PubMed Web of Science ®Google Scholar